Back to Pennsylvania

HB377 • 2025

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for prohibited acts and penalties.

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for prohibited acts and penalties.

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
KUZMA
Last action
2026-06-18
Official status
Referred to JUDICIARY, June 18, 2026
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for prohibited acts and penalties.

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for prohibited acts and penalties.

What This Bill Does

  • An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for prohibited acts and penalties.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-06-18 S

    In the Senate

  2. 2026-06-18 JUDICIARY

    Referred to JUDICIARY, June 18, 2026

  3. 2026-06-15 APPROPRIATIONS

    Re-reported as committed, June 15, 2026

  4. 2026-06-15 H

    Third consideration and final passage, June 15, 2026 (200-2)

  5. 2026-06-15 H

    (Remarks see House Journal Page ), June 15, 2026

  6. 2026-06-10 H

    Second consideration, June 10, 2026

  7. 2026-06-10 APPROPRIATIONS

    Re-committed to APPROPRIATIONS, June 10, 2026

  8. 2026-06-09 H

    Removed from table, June 9, 2026

  9. 2025-09-10 RULES

    Re-reported as committed, Sept. 10, 2025

  10. 2025-09-10 H

    Laid on the table, Sept. 10, 2025

  11. 2025-06-30 JUDICIARY

    Reported as committed, June 30, 2025

  12. 2025-06-30 H

    First consideration, June 30, 2025

  13. 2025-06-30 RULES

    Re-committed to RULES, June 30, 2025

  14. 2025-01-28 JUDICIARY

    Referred to JUDICIARY, Jan. 28, 2025

Official Summary Text

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for prohibited acts and penalties.

Current Bill Text

Read the full stored bill text
PRINTER'S NO. 333
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL
No. 377
Session of
2025
INTRODUCED BY KUZMA, VENKAT, COOPER, SCIALABBA, JAMES, SCHEUREN,
ZIMMERMAN, MARCELL, M. BROWN, KUTZ, HOGAN, MIHALEK, KAIL AND
TOMLINSON, JANUARY 28, 2025
REFERRED TO COMMITTEE ON JUDICIARY, JANUARY 28, 2025
AN ACT
Amending the act of April 14, 1972 (P.L.233, No.64), entitled
"An act relating to the manufacture, sale and possession of
controlled substances, other drugs, devices and cosmetics;
conferring powers on the courts and the secretary and
Department of Health, and a newly created Pennsylvania Drug,
Device and Cosmetic Board; establishing schedules of
controlled substances; providing penalties; requiring
registration of persons engaged in the drug trade and for the
revocation or suspension of certain licenses and
registrations; and repealing an act," further providing for
prohibited acts and penalties.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. Section 13(a) of the act of April 14, 1972
(P.L.233, No.64), known as The Controlled Substance, Drug,
Device and Cosmetic Act, is amended by adding a clause and the
section is amended by adding a subsection to read:
Section 13. Prohibited Acts; Penalties.--(a) The following
acts and the causing thereof within the Commonwealth are hereby
prohibited:
* * *
(41) The manufacture, delivery or possession with intent to
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
manufacture or deliver tianeptine or any salt, compound,
derivative or preparation of tianeptine by a person not
registered under this act or by a practitioner not registered or
licensed by the appropriate State board.
* * *
(f.1) Any person who knowingly or intentionally violates
clause (41) of subsection (a) is guilty of a felony and upon
conviction thereof shall be sentenced to imprisonment not
exceeding five years, or to pay a fine not exceeding fifteen
thousand dollars ($15,000), or both.
* * *
Section 2. This act shall take effect immediately.
20250HB0377PN0333 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12